 Home > Medical News > Latest Medical News > Astellas' menopause drug fezolinetant fails clinical trial in Asia

Astellas' menopause drug fezolinetant fails clinical trial in Asia

 Last Update: 2022-04-27
 Source: Internet
 Author: User

Tags

3 4 1 8

non hdl

Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

CompilationFan Dongdong

A few days ago, Astellas’s $550 million bet on menopause drug fezolinetant suffered a setback

The MOONLIGHT 1 trial, an ongoing randomized Phase 3 clinical trial, enrolled 302 female patients in Mainland China, Taiwan, and South Korea who were randomly assigned to receive a 30 mg dose of fezolinetant or placebo , for 24 weeks

Results of the trial showed that after 12 weeks, women in the fezolinetant-treated group had an improvement in hot flashes from baseline, but the difference was not statistically significant compared to women in the placebo group

It is unclear why fezolinetant failed to beat placebo in Asian trials

In 2017, Astellas announced the completion of the $550 million acquisition of Belgian biotech company Ogeda, through which Astellas acquired fezolinetant

For now, the regulatory conundrum for Astellas is how long the impact of the consequences of this trial failure will last

Reference source:

This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

Related Products

L-Ascorbate-2-Monophosphate Feed Grade

CAS No.: 109620-90-8

Feed Grade

Potassium Sorbate from reliable manufacturer

CAS No.: 590-00-1

Food Grade

Doxycycline Hydrochloride

CAS No.: 10592-13-9

Pharmaceutical Grade

Hot Tags

united states jobs(223)

jobs united states(236)

1 year treasury(277)

1 year subscription(296)

single use technology(195)

announcements today(81)

ups united states(221)

united states logo(227)

80 20 company(94)

healthy food name(42)

Hot Articles

The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.